Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Meghani, Salimah H.	University Of Pennsylvania United States	Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study	3R01CA270483-04S1	Gabriela Riscuta, M.D., CNS
Mehrara, Babak J	Sloan-Kettering Inst Can Research United States	Mechanisms of racial disparity in breast cancer-related lymphedema	5R01CA278599-03
Mehta, Anand S.	Medical University Of South Carolina United States	Glycan Biomarkers for Cholangiocarcinoma	1R01CA289381-01A1	Sidney Fu, M.D.
Melemedjian, Ohannes Kevork	University Of Maryland Baltimore United States	Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy	4R01CA249939-02	Rachel Altshuler, Ph.D.
Mello-Thoms, Claudia R	University Of Iowa United States	Satisfaction of Search in Breast Cancer Detection	5R01CA259048-05
Metzger, Gregory John	University Of Minnesota United States	Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI	4R01CA241159-05	Guillermo Marquez, Ph.D.
Milanovich, Samuel J.	Sanford Research/Usd United States	Sanford Community Cancer Program of the North Central Plains (NCORP)	3UG1CA189825-11S1	Vanessa A. White, M.P.H.
Milbury, Kathrin	University Of Tx Md Anderson Can Ctr United States	Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers	4R37CA231522-07	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Miyano, Masaru	Beckman Research Institute/City Of Hope United States	Evaluating the ELF5 Clock as a Biomarker in Breast Cancer Prevention Trials	1R03CA300614-01	Sidney Fu, M.D.
Morilak, David A	University Of Texas Hlth Science Center United States	Therapy-induced cognitive impairment in a rat model of prostate cancer	5R01CA285183-03	John Clifford, Ph.D.
Morin, Olivier	University Of California, San Francisco United States	Development of a Personalized Voxel-wise Prediction of Brain Metastases using Multi-Parametric MR Imaging to Reduce Treatment Toxicity	1R01CA292043-01A1	Marjorie Perloff, M.D.
Moscicki, Anna-Barbara	University Of California Los Angeles United States	Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies	5R01CA281293-03	Maria Silvina Frech, Ph.D., M.S.
Moses, John Edward	Cold Spring Harbor Laboratory United States	Discovery of Natural Products and Natural Product Derivatives as Inhibitors of KLK6 to Prevent the Progression of Preneoplastic Ductal Pancreatic Cancer	1UG3CA290364-01A1	Altaf Mohammed, Ph.D.
Mosher, Catherine E	Indiana University Indianapolis United States	Acceptance and Commitment Therapy for Patient Fatigue Interference and Caregiver Burden in Advanced Gastrointestinal Cancer	5R01CA289486-02
Mu, Ping	Yale University United States	Unveiling the Role of UBE2J1 as the E2 Ubiquitin Conjugating Enzyme in Androgen Receptor Degradation	5R01CA292949-03	Indu Kohaar, Ph.D., M.Phil., M.Sc.